Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

NCT00226746 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Carcinoma, Pancreatic Ductal

Interventions

DRUG: Paclitaxel and gemcitabine

Sponsor

New York Presbyterian Brooklyn Methodist Hospital